Pay in 4 interest-free payments of $7.08 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Lixisenatide OD is indicated for the treatment of adults with type 2 diabetes to achieve glycemic control in combination with oral glucose-lowering drugs and/or basal insulin when these, together with diet and exercise, do not provide adequate glycemic control
Cell and molecular biology of the incretin hormones glucagon-like peptide-I and glucose-dependent insulin releasing polypeptide
Promrat K, Kleiner DE, Niemeier HM, et al
MD simulations Initial wild-type GLP-1R model for MD simulations was obtained from the GLP-1R-Fab7F38 structure with modifications: (1) antibody (Fab7F38) and fusion protein (rubredoxin) were removed
US$ 26.48
US$ 24.71
US$ 29.20
US$ 28.02
US$ 29.65
US$ 27.82
